Elevated levels of CCL2 are often associated with the progression of diseases, such as esophageal cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, gastric cancer, and ovarian cancer [40]. This evidence concerns the gene CCL2 and esophageal cancer.